Effects of vasoactive drugs on renal vascular resistance in obstructive disease.
D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology; D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply*; D008026:Ligation; D008729:Methoxamine / Q000008:administration & dosage / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000187:drug effects; D014513:Ureter / Q000601:surgery; D014517:Ureteral Obstruction / Q000209:etiology / Q000503:physiopathology*; D014655:Vascular Resistance / Q000187:drug effects*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D000804:Angiotensin II; D008729:Methoxamine; D007545:Isoproterenol; D000109:Acetylcholine; D004298:Dopamine; D004837:Epinephrine